Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 2020; Volume 374,Issue 1

Minireview

  • Analgesia with Gabapentin and Pregabalin May Involve <em>N</em>-Methyl-<span class="sc">d</span>-Aspartate Receptors, Neurexins, and Thrombospondins
    You have access
    Analgesia with Gabapentin and Pregabalin May Involve N-Methyl-d-Aspartate Receptors, Neurexins, and Thrombospondins
    Charles P. Taylor and Eric W. Harris
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 161-174; DOI: https://doi.org/10.1124/jpet.120.266056

Behavioral Pharmacology

  • You have access
    Evaluation of the Reinforcing Strength of Phendimetrazine Using a Progressive-Ratio Schedule of Reinforcement in Rhesus Monkeys
    Molly Minkiewicz, Paul W. Czoty, Bruce E. Blough and Michael A. Nader
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 1-5; DOI: https://doi.org/10.1124/jpet.120.264952
  • You have access
    The Effects of Eating a High Fat Diet on Sensitivity of Male and Female Rats to Methamphetamine and Dopamine D1 Receptor Agonist SKF 82958
    Jeremiah Ramos, Ethan J. Hardin, Alice H. Grant, Grace Flores-Robles, Adrian T. Gonzalez, Bryan Cruz, Arantxa K. Martinez, Nina M. Beltran and Katherine M. Serafine
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 6-15; DOI: https://doi.org/10.1124/jpet.119.263293
  • You have access
    Extending the Specificity of DRL 72-s Behavior for Screening Antidepressant-Like Effects of Glutamatergic Clinically Validated Anxiolytic or Antidepressant Drugs in Rats
    Gerard J. Marek and Allyson A. Salek
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 200-210; DOI: https://doi.org/10.1124/jpet.119.264069

Cellular and Molecular

  • You have access
    7α,25-Dihydroxycholesterol Suppresses Hepatocellular Steatosis through GPR183/EBI2 in Mouse and Human Hepatocytes
    Jin Huang, Seung-Jin Lee, Saeromi Kang, Man Ho Choi and Dong-Soon Im
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 142-150; DOI: https://doi.org/10.1124/jpet.120.264960

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK-Positive Lung Cancer
    N. Shrestha, A.R. Bland, R.L. Bower, R.J. Rosengren and J.C. Ashton
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 134-140; DOI: https://doi.org/10.1124/jpet.120.266049

Drug Discovery and Translational Medicine

  • You have access
    The Development and Characterization of an scFv-Fc Fusion–Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse
    Charles E. Hay, Laura E. Ewing, Michael D. Hambuchen, Shannon M. Zintner, Juliana C. Small, Chris T. Bolden, William E. Fantegrossi, Paris Margaritis, S. Michael Owens and Eric C. Peterson
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 16-23; DOI: https://doi.org/10.1124/jpet.119.261180
  • Open Access
    Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities
    Marie-Laure Ozoux, Véronique Briand, Michel Pelat, Fabrice Barbe, Paul Schaeffer, Philippe Beauverger, Bruno Poirier, Jean-Michel Guillon, Frédéric Petit, Jean-Michel Altenburger, Jean-Pierre Bidouard and Philip Janiak
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 24-37; DOI: https://doi.org/10.1124/jpet.120.265496
  • You have access
    Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice
    Corinne G. Jolivalt, Katie E. Frizzi, May Madi Han, Andre J. Mota, Lucie S. Guernsey, Lakshmi P. Kotra, Paul Fernyhough and Nigel A. Calcutt
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 44-51; DOI: https://doi.org/10.1124/jpet.120.265447
  • You have access
    The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy
    Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 74-83; DOI: https://doi.org/10.1124/jpet.119.263392
  • You have access
    TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder
    Hiroya Mizutani, Fukumitsu Sakakibara and Eiji Sasaki
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 84-92; DOI: https://doi.org/10.1124/jpet.119.264572
  • Open Access
    Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide
    Leon F. Garcia-Martinez, Carol J. Raport, Ethan W. Ojala, Benjamin Dutzar, Katie Anderson, Erica Stewart, Brian Kovacevich, Brian Baker, Jens Billgren, Michelle Scalley-Kim, Charlie Karasek, Dan Allison and John A. Latham
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 93-103; DOI: https://doi.org/10.1124/jpet.119.264671
  • Open Access
    Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease
    Susanna Waters, Clas Sonesson, Peder Svensson, Joakim Tedroff, Manolo Carta, Elisabeth Ljung, Jenny Gunnergren, Malin Edling, Boel Svanberg, Anne Fagerberg, Johan Kullingsjö, Stephan Hjorth and Nicholas Waters
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 113-125; DOI: https://doi.org/10.1124/jpet.119.264226
  • Open Access
    Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy
    Niu Shin, Matthew Stubbs, Holly Koblish, Eddy W. Yue, Maxim Soloviev, Brent Douty, Kathy He Wang, Qian Wang, Mingming Gao, Patricia Feldman, Gengjie Yang, Leslie Hall, Michael Hansbury, Sybil O’Connor, Lynn Leffet, Robert Collins, Kamna Katiyar, Xin He, Paul Waeltz, Paul Collier, Jin Lu, Yun-Long Li, Yanlong Li, Phillip C.C. Liu, Timothy Burn, Maryanne Covington, Sharon Diamond, Dana Shuey, Alan Roberts, Swamy Yeleswaram, Greg Hollis, Brian Metcalf, Wenqing Yao, Reid Huber, Andrew Combs, Robert Newton and Peggy Scherle
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 211-222; DOI: https://doi.org/10.1124/jpet.120.265538

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Pharmacological Screening Identifies SHK242 and SHK277 as Novel Arginase Inhibitors with Efficacy against Allergen-Induced Airway Narrowing In Vitro and In Vivo
    M.P.M. van den Berg, S.H. Kurhade, H. Maarsingh, S. Erceg, I.R. Hulsbeek, P.H. Boekema, L.E.M. Kistemaker, M. van Faassen, I.P. Kema, P.H. Elsinga, A. Dömling, H. Meurs and R. Gosens
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 62-73; DOI: https://doi.org/10.1124/jpet.119.264341
  • You have access
    Fluvastatin Induces Apoptosis in Primary and Transformed Mast Cells
    Patrick A. Paez, Motunrayo Kolawole, Marcela T. Taruselli, Siddarth Ajith, Jordan M. Dailey, Sydney A. Kee, Tamara T. Haque, Brian O. Barnstein, Jamie Josephine Avila McLeod, Heather L. Caslin, Kasalina N. Kiwanuka, Yoshihiro Fukuoka, Quang T. Le, Lawrence B. Schwartz, David B. Straus, David A. Gewirtz, Rebecca K. Martin and John J. Ryan
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 104-112; DOI: https://doi.org/10.1124/jpet.119.264234

Metabolism, Transport, and Pharmacogenomics

  • You have access
    ABCG2 Deficiency Does Not Alter Dolutegravir Metabolism and Pharmacokinetics
    Junjie Zhu, Xin Tian, Amina I. Shehu, Deborah K. McMahon and Xiaochao Ma
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 38-43; DOI: https://doi.org/10.1124/jpet.119.264424
  • You have access
    Ezetimibe Markedly Reduces Hepatic Triglycerides and Cholesterol in Rats Fed on Fish Oil by Increasing the Expression of Cholesterol Efflux Transporters
    Yuji Tanaka, Takanori Ikeda, Hiroshi Ogawa and Toshinori Kamisako
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 175-183; DOI: https://doi.org/10.1124/jpet.120.265660
  • You have access
    Evolution of the Systems Pharmacokinetics-Pharmacodynamics Model for Antibody-Drug Conjugates to Characterize Tumor Heterogeneity and In Vivo Bystander Effect
    Aman P. Singh, Gail M. Seigel, Leiming Guo, Ashwni Verma, Gloria Gao-Li Wong, Hsuan-Ping Cheng and Dhaval K. Shah
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 184-199; DOI: https://doi.org/10.1124/jpet.119.262287
  • You have access
    Simultaneous Target-Mediated Drug Disposition Model for Two Small-Molecule Compounds Competing for Their Pharmacological Target: Soluble Epoxide Hydrolase
    Nan Wu, Bruce D. Hammock, Kin Sing Stephen Lee and Guohua An
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 223-232; DOI: https://doi.org/10.1124/jpet.120.265330

Neuropharmacology

  • Open Access
    Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain
    Émilie Eiselt, Valérie Otis, Karine Belleville, Gaoqiang Yang, Alain Larocque, Anthony Régina, Michel Demeule, Philippe Sarret and Louis Gendron
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 52-61; DOI: https://doi.org/10.1124/jpet.119.263566
  • You have access
    Effects of a Novel Psychomotor Stabilizer, IRL790, on Biochemical Measures of Synaptic Markers and Neurotransmission
    Kristina Becanovic, Maria Vittoria de Donno, Vasco C. Sousa, Joakim Tedroff and Per Svenningsson
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 126-133; DOI: https://doi.org/10.1124/jpet.119.264754
  • You have access
    Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male Mice
    Alexa Torrens, Valentina Vozella, Hannah Huff, Brandon McNeil, Faizy Ahmed, Andrea Ghidini, Stephen V. Mahler, Marilyn A. Huestis, Aditi Das and Daniele Piomelli
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 151-160; DOI: https://doi.org/10.1124/jpet.120.265892

Erratum

  • You have access
    Correction to “Menaquinone-4 Accelerates Calcification of Human Aortic Valve Interstitial Cells in High-Phosphate Medium through PXR”
    Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 141; DOI: https://doi.org/10.1124/jpet.119.263160err
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 374 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 374, Issue 1
1 Jul 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Behavioral Pharmacology
  • Cellular and Molecular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics